Autopsy report · NCT00189579
Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer
Cause of deathNo reason given
Life of this trial
- 45 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- ARCAGY/ GINECO GROUP
- Sponsor type
- University, hospital or other
- Conditions
- Ovarian Cancer
- Interventions
- Herceptin
- Participants
- 45 (planned, not actual)
- Sites
- 1
- Countries
- France
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.